Innovative radiotherapy controls late effects in Hodgkin lymphoma in paediatric patients

Radiotherapy is a highly effective modality for the local control of Hodgkin lymphoma and is commonly included in combined-modality treatment regimens. Concerns about late effects—particularly for children, and adolescents and young adults (AYA)—have fueled advances in radiotherapeutic planning and delivery, including the recent development of involved site radiotherapy (ISRT). This review introduces ISRT and its emerging role in Hodgkin lymphoma management.

Oncology Nurse Advisor